230 related articles for article (PubMed ID: 32610384)
1. [The expression of p53 protein and its clinicopathological features and prognosis of esophageal spindle cell carcinoma].
Rong LL; Xue LY; Xue XM; Li J; Lyu N
Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):715-720. PubMed ID: 32610384
[No Abstract] [Full Text] [Related]
2. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.
Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL
Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919
[TBL] [Abstract][Full Text] [Related]
4. Yield of p53 expression in esophageal squamous cell cancer and its relationship with survival.
Sankalecha TH; Gupta SJ; Gaikwad NR; Shirole NU; Kothari HG
Saudi J Gastroenterol; 2017; 23(5):281-286. PubMed ID: 28937022
[TBL] [Abstract][Full Text] [Related]
5. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Clinicopathological Characteristics and Prognosis of Esophageal Squamous Cell Carcinoma with Intramural Metastases and Multiple Primary Carcinomas.
Cheng N; Li W; Wang B; Li Z; Yang Z; Chen R; Xue L
World J Surg; 2023 Mar; 47(3):707-716. PubMed ID: 36437350
[TBL] [Abstract][Full Text] [Related]
7. Three-gene immunohistochemical panel predicts progression and unfavorable prognosis in esophageal squamous cell carcinoma.
Yu J; Zheng Y; Han XP; Peng H; Pang LJ; Li F; Chen Y; Cui X
Hum Pathol; 2019 Jun; 88():7-17. PubMed ID: 30537494
[TBL] [Abstract][Full Text] [Related]
8. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
Gong L; Mao W; Chen Q; Jiang Y; Fan Y
Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.
Saemi N; Khoshnevis J; Akbari ME; Meysamie A; Korourian A; Gholizadeh B; Larijani L; Moradi A; Baikpour M; Baikpour M; Zham H
J Gastrointest Cancer; 2018 Mar; 49(1):35-40. PubMed ID: 27975182
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.
Zhang D; Zhang W; Liu W; Mao Y; Fu Z; Liu J; Huang W; Zhang Z; An D; Li B
Radiother Oncol; 2017 Jul; 124(1):155-160. PubMed ID: 28647401
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
12. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma].
Xue LY; Ren LQ; Luo W; Guan XJ; Zou SM; Zheng S; Bi R; Xie YQ; He ZG; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):150-4. PubMed ID: 17425843
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
[TBL] [Abstract][Full Text] [Related]
16. Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery.
Yamashita K; Makino T; Tanaka K; Yamasaki M; Yamamoto M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
World J Surg; 2017 Jun; 41(6):1566-1574. PubMed ID: 28108772
[TBL] [Abstract][Full Text] [Related]
17. No prognostic significance of p53 expression in esophageal squamous cell carcinoma.
Kanamoto A; Kato H; Tachimori Y; Watanabe H; Nakanishi Y; Kondo H; Yamaguchi H; Gotoda T; Muro K; Matsumura Y
J Surg Oncol; 1999 Oct; 72(2):94-8. PubMed ID: 10518106
[TBL] [Abstract][Full Text] [Related]
18. The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma.
Hiyoshi Y; Yoshida N; Watanabe M; Kurashige J; Baba Y; Sakamoto Y; Baba H
World J Surg; 2017 Feb; 41(2):480-486. PubMed ID: 27637603
[TBL] [Abstract][Full Text] [Related]
19. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
[TBL] [Abstract][Full Text] [Related]
20. p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
Yamasaki M; Miyata H; Fujiwara Y; Takiguchi S; Nakajima K; Nishida T; Yasuda T; Matsuyama J; Mori M; Doki Y
Ann Surg Oncol; 2010 Feb; 17(2):634-42. PubMed ID: 19941080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
